BeStock  
Stocks › Biotechnology › DNA

Ginkgo Bioworks DNA

US equityMarket cap rank #3607BiotechnologyAI medical concept stocks
$7.46 −$0.74 (-9.02%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.55 +1.21%
Open$7.93
Prev close$8.20
Day range$7.38 – $8.29
Volume2.51M
Market cap$483.59M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-2.3x
CheapRich

Below its usual level · 30th percentile, 5-year average -3.6x

Price / book1.6x
CheapRich

Around its usual level · 50th percentile, 5-year average 2.1x

#2596 of 5329 stocks by PB (1 = cheapest)

Price / sales4.8x
CheapRich

Around its usual level · 46th percentile, 5-year average 9.5x

#3881 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-62x-38x-14x9xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$18.65
Price vs. fair value-60.0%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.59 – 2.14 50% (pricier than usual) #2596 of 5329 (1 = cheapest)
PE -2.30 -2.64 -3.65 30% (cheaper than usual) –
PS 4.76 6.67 9.52 46% (cheaper than usual) #3881 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on DNA.

Sign in to join the discussion.

Scroll to Top